http://www.mersana.com
Mersana Therapeutics, Inc. Company Intro
Technology Mersana has developed highly differentiated and innovative antibody-drug conjugate (ADC) platforms, with both cytotoxic and immunostimulatory payloads, that allow for customization and optimization of ADCs for a given target and indication. As a result, we are designing ADCs to overcome the limitations of first-generation platforms by delivering therapeutics with greater efficacy and tolerability to […]
Industry
Healthcare
Mersana Therapeutics, Inc. Headquaters
840 Memorial Drive
Cambridge,02139
United States
Mersana Therapeutics, Inc. Share price
23 Oct 2020 02:06 GMT
$17.92
0.03 (0.17 %)
Mersana Therapeutics, Inc. Market cap
$1.273 B
WMC RANKING
2020
Mersana Therapeutics, Inc. # 219
BiotechnologyLatest Mersana Therapeutics, Inc. News
23 Oct 2020
Mersana Therapeutics Inc. (MRSN): Skating on Thin Ice? We ...
Mersana Therapeutics Inc. (NASDAQ:MRSN) went up by 3.97% from its latest closing price compared to the recent 1-year high of $26.64. The company's stock ...
23 Oct 2020
Mersana Therapeutics, Inc. (NASDAQ:MRSN) Stock Jumped ...
In last trading session, Mersana Therapeutics, Inc. (NASDAQ:MRSN) saw 1,605,756 shares changing hands with its beta currently measuring 2.38. Company's ...
23 Oct 2020
Mersana Therapeutics Inc. (MRSN) last month performance of ...
Mersana Therapeutics Inc. (NASDAQ: MRSN) open the trading on October 22, 2020, with great promise as it jumped 3.97% to $18.60. During the day, the stock ...
WMC Market Score
WMC Market to Revenue Score
| Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score | |
| Mersana Therapeutics, Inc. | 0.03 | 1.63 | 2.17 | 0 | 0 | 0 | 3.36 |
| Alexion Pharmaceuticals, Inc. | 100 | 13.22 | 100 | 0 | 0 | 0 | 100 |
| Vertex Pharmaceuticals Incorporated | 97.58 | 100 | 4.11 | 0 | 0 | 0 | 91.95 |
| 3SBio Inc. | 96.05 | 0 | 0 | 0 | 0 | 0 | 0 |
| Incyte Corporation | 40.27 | 14.26 | 7.25 | 0 | 0 | 0 | 18.99 |
Mersana Therapeutics, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Mersana Therapeutics, Inc. | $1,693 | $72,517 | $-69,750 | $1.273B | 219 |
| Alexion Pharmaceuticals, Inc. | $5,536,800 | $2,523,000 | $846,100 | $26.228B | 1 |
| Vertex Pharmaceuticals Incorporated | $5,402,685 | $2,634,428 | $2,080,775 | $54.719B | 2 |
| 3SBio Inc. | ¥5,318,091 | ¥3,085,221 | ¥973,717 | ¥19.699B | 3 |
| Incyte Corporation | $2,229,409 | $1,622,822 | $446,906 | $19.79B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Mersana Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors
Mersana Therapeutics, Inc. Post vs Top 4 Industry Competitors
Book a demo
A free one-on-one demo with one of our team and see exactly what the WMC business intelligence platform can do for your organisation.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
